Efalizumab-induced severe thrombocytopenia can be resolved

Francesca Prignano, F Zanieri, S Mokhtarzadeh, T LottiUniversity Unit of Dermatology and Physiotherapy, School of Medicine, University of Florence, Florence, ItalyAbstract: Efalizumab is a monoclonal a humanized recombinant IgG1 monoclonal antibody which targets the CD11a, the alpha-subunit of LFA-1...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Francesca Prignano, F Zanieri, S Mokhtarzadeh, T Lotti
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://doaj.org/article/0c08f4768c4943ccba5044ea7fd8453e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!